ALB and cancer: With respect to cancers of specific types, albumin levels were significantly inversely associated with risks of lung cancer (Q2 vs. Q1: HR 0.82, 95% CI 0.60–1.12; Q3 vs. Q1: HR 0.68, 95% CI 0.51–0.90; Q4 vs. Q1: HR 0.70, 95% CI 0.52–0.95), colorectal cancer (Q2 vs. Q1: HR 0.87, 95% CI 0.57–1.34; Q3 vs. Q1: HR 0.95, 95% CI 0.65–1.38; Q4 vs. Q1: HR 0.43, 95% CI 0.26–0.72), and liver cancer (Q2 vs. Q1: HR 0.55, 95% CI 0.31–0.95; Q3 vs. Q1: HR 0.44, 95% CI 0.26–0.73; Q4 vs. Q1: HR 0.59, 95% CI 0.36–0.95).